Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
from Sanofi - Aventis Groupe https://ift.tt/d2CQFPn
via IFTTT
Press Release: Sarclisa induction treatment demonstrated significantly improved progression-free survival in patients with newly diagnosed multiple myeloma eligible for transplant
https://ift.tt/EcAG0nQ
from Sanofi - Aventis Groupe https://ift.tt/d2CQFPn
via IFTTT
from Sanofi - Aventis Groupe https://ift.tt/d2CQFPn
via IFTTT
0 Comments
Please ,
Do not enter any kind of span link